skip to Main Content

Drug funded study lies about effects of statins…they show NO BENEFITS for elderly

Dr Zoe Harcombe,
Low Carb Down Under
presents episode 275: Dr Zoe Harcombe

Article, Feb 2019, The Times of London…
-from Lancet article, 2Feb2019,
-by CTSU (Clinical Trials Support Unit of Oxford University)

CTSU (Clinical Trials Support Unit of Oxford University)
-privately funded by pharmaceutical companies
-will not share their data

“8000 deaths could be prevented”
-not in the published paper
-only in the press release (not peer-reviewed)

Deaths: statins vs control: 0.95 (95% CI 0.83-1.07)
Primary prevention: 70-75’s: 0.84 (CI 0.70-1.10)
0ver 75s: 0.92 (CI 0.73-1.16)

Confidence Interval (CI)
-describe how uncertain the estimated difference (p-value)
is between two treatment groups
-if the CI between groups includes 1,
then the groups are not significantly different

BMJ (British Medical Journal)
-Nigel Hawkes, author, April 2019

Dr Harcombe, “If the CTSU, with their $350m+ funding,
cannot find evidence…there is no benefit”

Patient leaflet for Lipitor, $27b profits for Pfizer…
-this statin is contraindicated for 70+ years of age

BMJ article, 2016: Lack of an association or an inverse
association between LDL cholesterol and mortality in the elderly
-lower cholesterol = more likely to die


To access her citations:
Go to her website:
Here find a list of all the slides from her presentation.
Each slide has the title and the reference for the study she cites with its link.

Dr ZoeHarcombe:

Original youtube:

This site will never use corruptible, epidemiological survey research.
For each short/sharable video, the original Youtube links are provided

None of this content is intended to be individual, personalized medical advice.

We hope you find value for yourself in these short videos &
find them easy to share with loved ones!